Compare StocksJNJ vs UHS

Johnson & Johnson (JNJ) vs Universal Health Services, Inc. (UHS): Which Is the Better Buy in 2026?

As of 2026-06-19, JNJ is fairly valued at $228, with a DCF intrinsic value of $281 and a margin of safety of 19%. UHS is undervalued at $141, with an intrinsic value of $465 and a margin of safety of 70%. Of the two, UHS has the wider margin of safety.

JNJ
Johnson & Johnson
$228.39
VS
UHS
Universal Health Services, Inc.
$141.17

Rewards

JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
UHS
  • Free cash flow has grown at a 46.5% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Share count has been reduced by 14% over the past 4 years through buybacks, increasing each share's claim on earnings.
  • Each dollar of retained earnings has created $2.83 of earning power — management is an exceptional capital allocator.

Risks

JNJ
  • Trailing P/E of 26.5x is 33% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 3.06 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $2.4M worth of stock in the past 3 months — significant insider liquidation.
UHS
  • FCF yield of 7.6% suggests reasonable valuation assuming continued moderate growth.

Key Valuation Metrics

Learn more →
JNJ
UHS
Valuation
$19.31B
Free Cash Flow
$650.82M
3.51%
FCF Yield
7.62%
26.46
Trailing P/E
5.90
17.96
Forward P/E
5.57
Quality & Moat
15.32%
ROIC
12.33%
26.42%
ROE
21.37%
68.04%
Gross Margin
44.23%
3.06
PEG Ratio
1.02
Balance Sheet Safety
0.41
Net Debt / Equity
0.66
N/A
Interest Coverage
N/A
0.96
Net Debt / EBITDA
1.88
2.22%
Dividend Yield
0.54%
JNJ: 7Ties: 1UHS: 4
JNJUHS

Historical Fundamentals

Learn more →
JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

UHS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
UHS
$1.05
created per $1 retained over 3 years
Value Creator
Σ Retained
$3.19B
Δ Market Cap
+$3.36B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
JNJ
18.6% Margin of Safety
Price is 18.6% below estimated fair value
Current Price: $228.39
Fair Value: $280.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
UHS
69.6% Margin of Safety
Price is 69.6% below estimated fair value
Current Price: $141.17
Fair Value: $465.09
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
JNJ

What growth rate is the market pricing in at $228?

+7.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.3%

The market implies +7.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.3%, reflecting heavy growth investment.

UHS

What growth rate is the market pricing in at $141?

-3.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.3%

The market implies -3.2% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +8.3%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
UHS
66/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
UHS
-2.44
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
JNJ
Insiders 0.1%Institutions 76.9%Retail & Other 23.1%
No. of Institutional Holders5,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
UHS
Insiders 4.8%Institutions 101.4%
No. of Institutional Holders916
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises
UHS
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
JNJ
1
Sells (3M)
13
Sells (12M)
Total value (12M): $103.65M
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
DECKER ROBERT J
Officer
$930,113
@ $165.06 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
UHS
0
Sells (3M)
3
Sells (12M)
Total value (12M): $1.20M
SUSSMAN ELLIOT J
Director
$128,099
@ $190.06 · 2026-03-13
NIMETZ WARREN J.
Director
$852,343
@ $223.30 · 2025-11-11
SUSSMAN ELLIOT J
Director
$217,799
@ $225.70 · 2025-10-29
SINGER MARIA RUDERMAN
Director
$210,053
@ $191.48 · 2025-05-14
SINGER MARIA RUDERMAN
Director
$179,161
@ $179.16 · 2025-03-10
SINGER MARIA RUDERMAN
Director
$308,516
@ $191.15 · 2024-12-11
SUSSMAN ELLIOT J
Director
$375,534
@ $218.08 · 2024-08-13
NIMETZ WARREN J.
Director
$749,552
@ $217.64 · 2024-08-12
CHEN-LANGENMAYR NINA
Director
$180,294
@ $212.11 · 2024-08-07
SUSSMAN ELLIOT J
Director
$533,616
@ $210.00 · 2024-07-26
MCDONNELL EILEEN C.
Director
$531,211
@ $209.55 · 2024-07-26
PETERSON MATTHEW JAY
Officer
$3.19M
@ $210.85 · 2024-07-26
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
JNJ
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
UHS
FearGreed
😨Fear(31/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
JNJ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
UHS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (31)
View JNJ Full AnalysisView UHS Full Analysis

Frequently Asked Questions: JNJ vs UHS

Is Johnson & Johnson or Universal Health Services, Inc. more undervalued in 2026?

Based on our discounted cash flow model, UHS trades at a 69.6% margin of safety (intrinsic value $465 vs. price $141), compared to JNJ's 18.6% margin of safety (intrinsic $281 vs. $228).

Which stock has a wider economic moat, Johnson & Johnson or Universal Health Services, Inc.?

JNJ scores 90/100 (Wide moat), while UHS scores 66/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Which company has better free cash flow, Johnson & Johnson or Universal Health Services, Inc.?

Universal Health Services, Inc. (UHS) generates a 7.6% free cash flow yield, compared to Johnson & Johnson's 3.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Johnson & Johnson or Universal Health Services, Inc.?

JNJ earns 15.3% ROIC versus UHS's 12.3%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Johnson & Johnson's or Universal Health Services, Inc.'s?

UHS's dividend earns a safety score of 88/100 (Very Safe), compared to JNJ's 79/100 (Safe). UHS has raised its dividend for 1 consecutive years.

JNJ vs UHS: Which Is the Better Buy in 2026? | SafetyMargin.io